January 21, 2014
Employees of Novartis Pharma had taken part in an in-house incentive program to support a clinical trial on its chronic myeloid leukemia (CML) drug Tasigna (nilotinib), where they jostled to win awards by collecting patient questionnaires. The Japanese arm of...read more